Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic...

Nov 3, 2009 1 related
 

IMO-2125 Induces Endogenous Interferons and Other Antiviral Proteins - News) today presents preclinical data on the mechanism by which IMO-2125 was shown to induce immune activation through Toll-like Receptor 9 (TLR9).... [read full story]                    

powered by
Add Comment
There are also 1 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies